Education
About Us
Working with TipRanks
Follow Us
Sqz Biotechnologies Company (SQZB)
:SQZB
Total Valuation
SQZ Biotechnologies has a market cap or net worth of $825.75K. The enterprise value is $329.48M.
Market Cap$825.75K
Enterprise Value$329.48M
Share Statistics
SQZ Biotechnologies has 29,491,125 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,491,125
Owned by Insiders―
Owned by Institutions5.49%
Financial Efficiency
SQZ Biotechnologies’s return on equity (ROE) is -1.39 and return on invested capital (ROIC) is -76.74%.
Return on Equity (ROE)-1.39
Return on Assets (ROA)-0.74
Return on Invested Capital (ROIC)-76.74%
Return on Capital Employed (ROCE)-0.89
Revenue Per Employee396.77K
Profits Per Employee-1.50M
Employee Count53
Asset Turnover0.20
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of SQZ Biotechnologies is -0.27. SQZ Biotechnologies’s PEG ratio is -0.02.
PE Ratio-0.27
PS Ratio0.00
PB Ratio0.37
Price to Fair Value0.37
Price to FCF-0.25
Price to Operating Cash Flow-0.26
PEG Ratio-0.02
Income Statement
In the last 12 months, SQZ Biotechnologies had revenue of 21.03M and earned -79.46M in profits. Earnings per share was -2.76.
Revenue21.03M
Gross Profit9.35M
Operating Income-80.68M
Pretax Income-79.46M
Net Income-79.46M
EBITDA-64.14M
Earnings Per Share (EPS)-2.76
Cash Flow
In the last 12 months, operating cash flow was -74.33M and capital expenditures -213.00K, giving a free cash flow of -74.55M billion.
Operating Cash Flow-74.33M
Free Cash Flow-74.55M
Free Cash Flow per Share-2.53
Dividends & Yields
SQZ Biotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change-25.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)47.70
Average Volume (3m)26.95K
Important Dates
SQZ Biotechnologies upcoming earnings date is Nov 6, 2024, TBA Not Confirmed.
Last Earnings DateAug 1, 2024
Next Earnings DateNov 6, 2024
Ex-Dividend Date―
Financial Position
SQZ Biotechnologies as a current ratio of 3.12, with Debt / Equity ratio of 48.07%
Current Ratio3.12
Quick Ratio3.12
Debt to Market Cap0.32
Net Debt to EBITDA0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, SQZ Biotechnologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
SQZ Biotechnologies EV to EBITDA ratio is 0.23, with an EV/FCF ratio of 0.18.
EV to Sales-0.69
EV to EBITDA0.23
EV to Free Cash Flow0.18
EV to Operating Cash Flow0.18
Balance Sheet
SQZ Biotechnologies has $10.19M in cash and marketable securities with $21.47M in debt, giving a net cash position of $11.28M billion.
Cash & Marketable Securities$10.19M
Total Debt$21.47M
Net Cash$11.28M
Net Cash Per Share$0.38
Tangible Book Value Per Share$1.98
Margins
Gross margin is 45.60%, with operating margin of -353.04%, and net profit margin of -369.98%.
Gross Margin45.60%
Operating Margin-353.04%
Pretax Margin-369.98%
Net Profit Margin-369.98%
EBITDA Margin-298.64%
EBIT Margin-353.04%
Analyst Forecast
The average price target for SQZ Biotechnologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―